Bookmark and Share

Quest Diagnostics Warns Q3 Earnings to Miss Estimate

Laboratory test services provider, Quest Diagnostics Inc. (NYSE: DGX) expects fiscal third quarter profit to miss analysts’ estimation. The Company cited drop in number of tests ordered during the latter part of the quarter for a downbeat guidance. Quest Diagnostics now expects non-GAAP earnings of $1.02 a share down from its earlier projection of $1.15 a share. Analysts had forecasted earnings of $1.20 a share. The Company also anticipates revenue from continuing operations to come at $1.79 billion, which is below analysts’ expectation of $1.84 billion.


Leave a Reply

  

  

  

You can use these HTML tags

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>


-------------------------------------------------------------------------------------------------------------------------
All stories in DailyStocks.com are for informational purposes only. This is NOT a stock recommendation. This DailyStocks.com story is a daily light analysis featuring a stock with insider buying. With some caveats, insiders purchase a stock because they think the stock is going up. There are other factors to consider such as size of the transaction relative to their compensation and net worth. Sometimes, insiders might be propping a stock price up for future financing. Sometimes, the amount of insider buying are misread or misreported. Each month, DailyStocks releases a a summary of the stocks with insider buying. Sign up for the free monthly newsletter at DailyStocks.com . About Dailystocks.com: DailyStocks.com is the place where you can find stories about stocks with insider buying, where you can educate yourself about stock market investing, and where you can perform the stock search engine analysis – you enter a stock symbol, and you get a resulting page of stock ticker indexed links so that you do not have to type the stock symbol each time.